Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-27

FDA Approved: ROPINIROLE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for ropinirole submitted by Bionpharma Inc., under an already approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

SUPPL AP for ROPINIROLE (ROPINIROLE)